Pfizer Inc. (PFE) News & Corporate Actions | Announcements, Board Meetings, Splits, Bonuses, Rights Issues

{
  "main_header": {
    "sid": 1159109,
    "name": "Pfizer Inc.",
    "stock_name": "Pfizer Inc.",
    "full_name": "Pfizer Inc.",
    "name_url": "stocks-analysis/pfizer-inc",
    "exchange": 207,
    "exchangecode": "NYS",
    "country_id": 2,
    "currency": "USD",
    "cmp": "25.70",
    "chg": 0.13,
    "chgp": "0.51%",
    "dir": 1,
    "prev_price": "25.57",
    "mcapval": "235,718.04",
    "mcap": "Large Cap",
    "scripcode": "",
    "symbol": "",
    "ind_name": "Pharmaceuticals & Biotechnology",
    "ind_code": 2305,
    "indexname": "S&P 500",
    "isin": "US7170811035",
    "curr_date": "Dec 04",
    "curr_time": "",
    "bse_nse_vol": "70.91 M",
    "exc_status": "Active",
    "traded_date": "Dec 04, 2025",
    "traded_date_str": "2025 12 04",
    "score": "",
    "scoreText": "",
    "Live": 0,
    "market_time": 0,
    "is_blur": 1,
    "is_blur_class": "blur-register-score-header",
    "is_blur_url": "https://www.marketsmojo.com/mojofeed/register?redirect=/stocks-analysis/pfizer-inc-1159109-207&utm_source=Spage_Header_Score",
    "mojoone": {
      "ismore": 0
    }
  },
  "news": {
    "results": [
      {
        "title": "Pfizer Inc. Experiences Evaluation Revision Amid Mixed Market Signals and Performance Challenges",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/pfizer-inc-technical-trend-shifts-from-sideways-to-mildly-bullish-amid-stock-fluctuations-3619880",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/10/PfizerInc_technicaldot_3619880.png",
        "date": "2025-10-14 16:06:13",
        "description": "Pfizer Inc. has recently revised its evaluation amid ongoing market challenges. The company's stock price is currently at $24.73, reflecting a decline over the past year. Despite some technical indicators suggesting a mildly bullish trend, Pfizer's performance has significantly lagged behind broader market indices over the past three years."
      },
      {
        "title": "Pfizer Stock Forms Golden Cross, Signaling Potential Bullish Breakout Ahead",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/pfizer-stock-forms-golden-cross-signaling-potential-bullish-breakout-ahead-3617275",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/10/PfizerInc_goldencross_3617275.png",
        "date": "2025-10-13 15:19:06",
        "description": "Pfizer Inc. has recently achieved a Golden Cross, indicating a potential shift in market sentiment and increased investor confidence. Despite a challenging year, recent technical indicators show bullish trends, suggesting a possible turnaround. With a market capitalization of around $155.6 billion, Pfizer remains a key player in the pharmaceuticals sector."
      },
      {
        "title": "Is Pfizer Inc. technically bullish or bearish?",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/is-pfizer-inc-technically-bullish-or-bearish-3614491",
        "imagepath": "",
        "date": "2025-10-13 11:35:04",
        "description": "As of 10 October 2025, the technical trend for Pfizer Inc. has changed from sideways to mildly bullish. The weekly MACD is bullish, and the monthly MACD is mildly bullish, supporting the positive outlook. The daily moving averages also indicate a mildly bullish stance. However, the monthly Bollinger Bands show a bearish signal, which tempers the overall bullish sentiment. \n\nIn terms of performance, Pfizer has underperformed the S&P 500 across multiple periods, with a year-to-date return of -6.60% compared to the S&P 500's 11.41%, and a one-year return of -15.54% versus the S&P 500's 13.36%. Overall, the current technical stance is mildly bullish, but the significant underperformance relative to the benchmark raises caution...."
      },
      {
        "title": "Is Pfizer Inc. technically bullish or bearish?",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/is-pfizer-inc-technically-bullish-or-bearish-3612823",
        "imagepath": "",
        "date": "2025-10-12 11:23:35",
        "description": "As of 10 October 2025, the technical trend for Pfizer Inc. has changed from sideways to mildly bullish. The weekly MACD is bullish, while the monthly MACD is mildly bullish, supporting the overall positive stance. The daily moving averages also indicate a mildly bullish trend. However, the Bollinger Bands show a mixed signal with the weekly being mildly bullish and the monthly bearish. The KST and OBV are both bullish on the weekly and mildly bullish on the monthly, further contributing to the bullish outlook.\n\nDespite this mildly bullish stance, Pfizer's performance has lagged significantly compared to the S&P 500, with a year-to-date return of -6.60% versus the S&P 500's 11.41%, and a one-year return of -15.54% compared to the S&P 500's 13.36%. Overall, the current technical stance is mildly bullish, but the stock's underperformance against the benchmark raises caution...."
      },
      {
        "title": "Pfizer Inc. Stock Hits Day Low Amid Price Pressure, Reaches $26.39",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/pfizer-inc-stock-hits-day-low-amid-price-pressure-reaches-2639-3601736",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/10/PfizerInc_priceRelatedfactors_3601736.png",
        "date": "2025-10-07 22:21:29",
        "description": "Pfizer Inc. saw a significant stock decline today, contrasting with a slight increase in the S&P 500. Despite recent positive trends and strong financial metrics, including high return on capital and net profit growth, the stock's year-to-date performance remains negative, reflecting challenges over the past three years."
      },
      {
        "title": "Pfizer Inc. Experiences Revision in Stock Evaluation Amid Mixed Market Signals",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/pfizer-inc-technical-trend-shifts-from-bearish-to-mildly-bullish-amid-stock-price-changes-3601146",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/10/PfizerInc_technicaldot_3601146.png",
        "date": "2025-10-07 20:10:26",
        "description": "Pfizer Inc. has recently revised its market evaluation, with its stock currently priced at $26.43. The company has experienced significant volatility over the past year, with a high of $30.43 and a low of $20.91. Technical indicators show mixed signals, reflecting varied performance compared to the S&P 500."
      },
      {
        "title": "Is Pfizer Inc. technically bullish or bearish?",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/is-pfizer-inc-technically-bullish-or-bearish-3598854",
        "imagepath": "",
        "date": "2025-10-07 12:11:36",
        "description": "As of 3 October 2025, the technical trend for Pfizer Inc. has changed from bearish to mildly bullish. The weekly MACD is bullish, while the monthly MACD is mildly bullish, indicating positive momentum. The weekly KST is also bullish, and the monthly KST is mildly bullish, further supporting the bullish stance. However, the daily moving averages are mildly bearish, suggesting some short-term weakness. The Bollinger Bands show a mildly bullish trend on the weekly chart but are sideways on the monthly. The Dow Theory indicates a mildly bullish stance on the monthly timeframe.\n\nIn terms of performance, Pfizer's returns over the past week and month have outperformed the S&P 500, with a 10.82% return compared to 1.09% for the index over the past week, and a 6.23% return compared to 4.15% over the past month. However, year-to-date and longer-term returns remain negative compared to the S&P 500, highlighting ongoin..."
      },
      {
        "title": "Is Pfizer Inc. technically bullish or bearish?",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/is-pfizer-inc-technically-bullish-or-bearish-3593576",
        "imagepath": "",
        "date": "2025-10-06 12:01:55",
        "description": "As of 3 October 2025, the technical trend for Pfizer Inc. has changed from bearish to mildly bullish. The weekly MACD and KST indicators are bullish, while the monthly MACD and KST are mildly bullish. Bollinger Bands are bullish on both weekly and monthly time frames. The Dow Theory also indicates a mildly bullish stance on both weekly and monthly periods. However, daily moving averages are mildly bearish, which suggests some short-term weakness. \n\nIn terms of performance, Pfizer's returns over the past week and month have significantly outperformed the S&P 500, with returns of 15.19% and 10.41% respectively, while year-to-date and longer-term returns remain negative compared to the benchmark. Overall, the current technical stance is mildly bullish, driven by strong weekly indicators despite some mixed signals in the daily timeframe...."
      },
      {
        "title": "Is Pfizer Inc. technically bullish or bearish?",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/is-pfizer-inc-technically-bullish-or-bearish-3591649",
        "imagepath": "",
        "date": "2025-10-05 11:46:45",
        "description": "As of 3 October 2025, the technical trend for Pfizer Inc. has changed from bearish to mildly bullish. The weekly MACD and KST indicators are bullish, while the monthly MACD and KST are mildly bullish, supporting the overall positive stance. The Bollinger Bands are bullish on both weekly and monthly time frames. However, the daily moving averages indicate a mildly bearish sentiment. The Dow Theory also reflects a mildly bullish outlook on both weekly and monthly bases.\n\nIn terms of performance, Pfizer has outperformed the S&P 500 over the past week and month, with returns of 15.19% and 10.41% respectively, compared to the S&P 500's 1.09% and 4.15%. However, the longer-term returns show underperformance, particularly over the 3-year and 5-year periods, where Pfizer has declined by 37.99% and 20.58% respectively, while the S&P 500 has gained significantly.\n\nOverall, the current technical stance is mildly bulli..."
      }
    ],
    "total": 17,
    "sid": "1159109",
    "stock_news_url": "https://www.marketsmojo.com/news/pfizer-inc-1159109"
  },
  "announcements": "",
  "corporate_actions": {
    "msg": "No corporate action Found"
  }
}

News and Views

Pfizer Inc. Experiences Evaluation Revision Amid Mixed Market Signals and Performance Challenges

2025-10-14 16:06:13

Pfizer Inc. has recently revised its evaluation amid ongoing market challenges. The company's stock price is currently at $24.73, reflecting a decline over the past year. Despite some technical indicators suggesting a mildly bullish trend, Pfizer's performance has significantly lagged behind broader market indices over the past three years.

Pfizer Stock Forms Golden Cross, Signaling Potential Bullish Breakout Ahead

2025-10-13 15:19:06

Pfizer Inc. has recently achieved a Golden Cross, indicating a potential shift in market sentiment and increased investor confidence. Despite a challenging year, recent technical indicators show bullish trends, suggesting a possible turnaround. With a market capitalization of around $155.6 billion, Pfizer remains a key player in the pharmaceuticals sector.

Is Pfizer Inc. technically bullish or bearish?

2025-10-13 11:35:04

As of 10 October 2025, the technical trend for Pfizer Inc. has changed from sideways to mildly bullish. The weekly MACD is bullish, and the monthly MACD is mildly bullish, supporting the positive outlook. The daily moving averages also indicate a mildly bullish stance. However, the monthly Bollinger Bands show a bearish signal, which tempers the overall bullish sentiment. In terms of performance, Pfizer has underperformed the S&P 500 across multiple periods, with a year-to-date return of -6.60% compared to the S&P 500's 11.41%, and a one-year return of -15.54% versus the S&P 500's 13.36%. Overall, the current technical stance is mildly bullish, but the significant underperformance relative to the benchmark raises caution....

Is Pfizer Inc. technically bullish or bearish?

2025-10-12 11:23:35

As of 10 October 2025, the technical trend for Pfizer Inc. has changed from sideways to mildly bullish. The weekly MACD is bullish, while the monthly MACD is mildly bullish, supporting the overall positive stance. The daily moving averages also indicate a mildly bullish trend. However, the Bollinger Bands show a mixed signal with the weekly being mildly bullish and the monthly bearish. The KST and OBV are both bullish on the weekly and mildly bullish on the monthly, further contributing to the bullish outlook. Despite this mildly bullish stance, Pfizer's performance has lagged significantly compared to the S&P 500, with a year-to-date return of -6.60% versus the S&P 500's 11.41%, and a one-year return of -15.54% compared to the S&P 500's 13.36%. Overall, the current technical stance is mildly bullish, but the stock's underperformance against the benchmark raises caution....

Pfizer Inc. Stock Hits Day Low Amid Price Pressure, Reaches $26.39

2025-10-07 22:21:29

Pfizer Inc. saw a significant stock decline today, contrasting with a slight increase in the S&P 500. Despite recent positive trends and strong financial metrics, including high return on capital and net profit growth, the stock's year-to-date performance remains negative, reflecting challenges over the past three years.

Pfizer Inc. Experiences Revision in Stock Evaluation Amid Mixed Market Signals

2025-10-07 20:10:26

Pfizer Inc. has recently revised its market evaluation, with its stock currently priced at $26.43. The company has experienced significant volatility over the past year, with a high of $30.43 and a low of $20.91. Technical indicators show mixed signals, reflecting varied performance compared to the S&P 500.

Is Pfizer Inc. technically bullish or bearish?

2025-10-07 12:11:36

As of 3 October 2025, the technical trend for Pfizer Inc. has changed from bearish to mildly bullish. The weekly MACD is bullish, while the monthly MACD is mildly bullish, indicating positive momentum. The weekly KST is also bullish, and the monthly KST is mildly bullish, further supporting the bullish stance. However, the daily moving averages are mildly bearish, suggesting some short-term weakness. The Bollinger Bands show a mildly bullish trend on the weekly chart but are sideways on the monthly. The Dow Theory indicates a mildly bullish stance on the monthly timeframe. In terms of performance, Pfizer's returns over the past week and month have outperformed the S&P 500, with a 10.82% return compared to 1.09% for the index over the past week, and a 6.23% return compared to 4.15% over the past month. However, year-to-date and longer-term returns remain negative compared to the S&P 500, highlighting ongoin...

Is Pfizer Inc. technically bullish or bearish?

2025-10-06 12:01:55

As of 3 October 2025, the technical trend for Pfizer Inc. has changed from bearish to mildly bullish. The weekly MACD and KST indicators are bullish, while the monthly MACD and KST are mildly bullish. Bollinger Bands are bullish on both weekly and monthly time frames. The Dow Theory also indicates a mildly bullish stance on both weekly and monthly periods. However, daily moving averages are mildly bearish, which suggests some short-term weakness. In terms of performance, Pfizer's returns over the past week and month have significantly outperformed the S&P 500, with returns of 15.19% and 10.41% respectively, while year-to-date and longer-term returns remain negative compared to the benchmark. Overall, the current technical stance is mildly bullish, driven by strong weekly indicators despite some mixed signals in the daily timeframe....

Is Pfizer Inc. technically bullish or bearish?

2025-10-05 11:46:45

As of 3 October 2025, the technical trend for Pfizer Inc. has changed from bearish to mildly bullish. The weekly MACD and KST indicators are bullish, while the monthly MACD and KST are mildly bullish, supporting the overall positive stance. The Bollinger Bands are bullish on both weekly and monthly time frames. However, the daily moving averages indicate a mildly bearish sentiment. The Dow Theory also reflects a mildly bullish outlook on both weekly and monthly bases. In terms of performance, Pfizer has outperformed the S&P 500 over the past week and month, with returns of 15.19% and 10.41% respectively, compared to the S&P 500's 1.09% and 4.15%. However, the longer-term returns show underperformance, particularly over the 3-year and 5-year periods, where Pfizer has declined by 37.99% and 20.58% respectively, while the S&P 500 has gained significantly. Overall, the current technical stance is mildly bulli...

View All News